Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
868.55
Change Change %
-2.15 -0.25%

Updated:27 Nov, 2020, 15:58 PM IST

BSE
868.05
Change Change %
-2.45 -0.28%

Updated:27 Nov, 2020, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
11-08-2014 Buy 753.25 915.00
N/A
Target Hit Long (1Y)
11-08-2015

Bank of America Merrill Lynch maintains buy on Aurobindo Pharma

Raising FY15 and FY16 earnings per share estimates by 5 per cent and 4 per cent. US sales hit an all-time high of $187 million in the June quarter. Improving profitability will continue to drive re-rating. Expect margins to remain at 23-24 per cent levels.

Top
Listen to the latest songs, only on JioSaavn.com